hemoperfusion

Summary

Summary: Removal of toxins or metabolites from the circulation by the passing of blood, within a suitable extracorporeal circuit, over semipermeable microcapsules containing adsorbents (e.g., activated charcoal) or enzymes, other enzyme preparations (e.g., gel-entrapped microsomes, membrane-free enzymes bound to artificial carriers), or other adsorbents (e.g., various resins, albumin-conjugated agarose).

Top Publications

  1. ncbi Extracorporeal endotoxin removal for the treatment of sepsis: endotoxin adsorption cartridge (Toraymyxin)
    Hisataka Shoji
    Division of Planning and Science, Department of Blood Purification Medical Devices, Toray Medical Co, Tokyo, Japan
    Ther Apher Dial 7:108-14. 2003
  2. ncbi [Basics of hemoadsorption]
    Masaki Nakane
    Department of Anesthesiology, Fukushima Medical University School of Medicine
    Nippon Rinsho 62:22-8. 2004
  3. ncbi Hemodialysis is as effective as hemoperfusion for drug removal in carbamazepine poisoning
    Mihály Tapolyai
    Cleveland Clinic Florida, Fort Lauderdale, FL 33309, USA
    Nephron 90:213-5. 2002
  4. ncbi A novel adsorbent of circulating bacterial toxins and cytokines: the effect of direct hemoperfusion with CTR column for the treatment of experimental endotoxemia
    Takumi Taniguchi
    Department of Emergency and Critical Care Medicine, Graduate School of Medical Science, Kanazawa University, Japan
    Crit Care Med 34:800-6. 2006
  5. ncbi Efficacy of hemodialysis and charcoal hemoperfusion in carbamazepine overdose
    Maricel Pilapil
    Clin Toxicol (Phila) 46:342-3. 2008
  6. ncbi Low-density lipoprotein apheresis therapy with a direct hemoperfusion column: a Japanese multicenter clinical trial
    Hiromi Tasaki
    Second Department of Internal Medicine, University of Occupational and Environmental Health, School of Medicine, Kitakyushu, Japan
    Ther Apher Dial 10:32-41. 2006
  7. ncbi High-flux hemodialysis--an effective alternative to hemoperfusion in the treatment of carbamazepine intoxication
    J T Kielstein
    Division of Nephrology, Medical School, Hanover, Germany
    Clin Nephrol 57:484-6. 2002
  8. ncbi Sustained low-efficiency daily diafiltration with hemoperfusion as a therapy for severe star fruit intoxication: a report of two cases
    Chia Lin Wu
    Division of Nephrology, Department of Internal Medicine, Changhua Christian Hospital, Changhua, Taiwan
    Ren Fail 33:837-41. 2011
  9. ncbi Angiopoietin balance in septic shock patients with acute lung injury: effect of direct hemoperfusion with polymyxin B-immobilized fiber
    Itaru Ebihara
    Department of Nephrology, Mito Saiseikai General Hospital, Mito, Japan
    Ther Apher Dial 15:349-54. 2011
  10. ncbi Ex-vivo hemoperfusion (eHPS) of pig-lungs with whole human blood: effects of complement inhibition with a soluble C1-esterase-inhibitor
    H Schelzig
    University of Ulm, Dept of Thoracic and Vascular Surgery, Germany
    Ann Transplant 6:34-9. 2001

Detail Information

Publications174 found, 100 shown here

  1. ncbi Extracorporeal endotoxin removal for the treatment of sepsis: endotoxin adsorption cartridge (Toraymyxin)
    Hisataka Shoji
    Division of Planning and Science, Department of Blood Purification Medical Devices, Toray Medical Co, Tokyo, Japan
    Ther Apher Dial 7:108-14. 2003
    ..Further studies are now ongoing to establish Toraymyxin treatment as one of the options to treat sepsis and septic shock patients and to clarify the mechanisms involved in this therapy...
  2. ncbi [Basics of hemoadsorption]
    Masaki Nakane
    Department of Anesthesiology, Fukushima Medical University School of Medicine
    Nippon Rinsho 62:22-8. 2004
  3. ncbi Hemodialysis is as effective as hemoperfusion for drug removal in carbamazepine poisoning
    Mihály Tapolyai
    Cleveland Clinic Florida, Fort Lauderdale, FL 33309, USA
    Nephron 90:213-5. 2002
    Although most authors recommend charcoal hemoperfusion (CHP) for the removal of carbamazepine (CBZ) in acute CBZ poisoning, we present a case where we had the chance to compare CHP with hemodialysis (HD)...
  4. ncbi A novel adsorbent of circulating bacterial toxins and cytokines: the effect of direct hemoperfusion with CTR column for the treatment of experimental endotoxemia
    Takumi Taniguchi
    Department of Emergency and Critical Care Medicine, Graduate School of Medical Science, Kanazawa University, Japan
    Crit Care Med 34:800-6. 2006
    ....
  5. ncbi Efficacy of hemodialysis and charcoal hemoperfusion in carbamazepine overdose
    Maricel Pilapil
    Clin Toxicol (Phila) 46:342-3. 2008
  6. ncbi Low-density lipoprotein apheresis therapy with a direct hemoperfusion column: a Japanese multicenter clinical trial
    Hiromi Tasaki
    Second Department of Internal Medicine, University of Occupational and Environmental Health, School of Medicine, Kitakyushu, Japan
    Ther Apher Dial 10:32-41. 2006
    ..We conclude that the new type of LDL adsorption column, one that deals with whole blood, is a promising apheresis therapy for FH patients in view of its efficacy, reduced time for treatment, and safety...
  7. ncbi High-flux hemodialysis--an effective alternative to hemoperfusion in the treatment of carbamazepine intoxication
    J T Kielstein
    Division of Nephrology, Medical School, Hanover, Germany
    Clin Nephrol 57:484-6. 2002
    ..In acute intoxication, charcoal hemoperfusion is employed for removal of the drug...
  8. ncbi Sustained low-efficiency daily diafiltration with hemoperfusion as a therapy for severe star fruit intoxication: a report of two cases
    Chia Lin Wu
    Division of Nephrology, Department of Internal Medicine, Changhua Christian Hospital, Changhua, Taiwan
    Ren Fail 33:837-41. 2011
    ..of choice for severe star fruit intoxication may be continuous renal replacement therapy with or without hemoperfusion. We report two cases of star fruit intoxication with stage V CKD (one case is predialysis) presenting with ..
  9. ncbi Angiopoietin balance in septic shock patients with acute lung injury: effect of direct hemoperfusion with polymyxin B-immobilized fiber
    Itaru Ebihara
    Department of Nephrology, Mito Saiseikai General Hospital, Mito, Japan
    Ther Apher Dial 15:349-54. 2011
    ..Polymyxin B-immobilized fiber column hemoperfusion is effective for sepsis-induced ALI...
  10. ncbi Ex-vivo hemoperfusion (eHPS) of pig-lungs with whole human blood: effects of complement inhibition with a soluble C1-esterase-inhibitor
    H Schelzig
    University of Ulm, Dept of Thoracic and Vascular Surgery, Germany
    Ann Transplant 6:34-9. 2001
    ..We developed an ex-vivo hemoperfusion (EHP) system to investigate pathophysiology of HAR in the lung...
  11. ncbi Beneficial effect of polymyxin B-immobilized fiber column (PMX) hemoperfusion treatment on acute exacerbation of idiopathic pulmonary fibrosis
    Yoshitsugu Seo
    4th Department of Internal Medicine, Nippon Medical School, 1-1-5 Sendagi Bunkyo-ku, Tokyo 113-8603, Japan
    Intern Med 45:1033-8. 2006
    OBJECTIVE: This study was aimed to investigate the effect of polymyxin B-immobilized fiber column (PMX) hemoperfusion treatment on the acute exacerbation of idiopathic pulmonary fibrosis (IPF)...
  12. ncbi Arresting dialysis-related amyloidosis: a prospective multicenter controlled trial of direct hemoperfusion with a beta2-microglobulin adsorption column
    Fumitake Gejyo
    Division of Clinical Nephrology and Rheumatology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Japan
    Artif Organs 28:371-80. 2004
    We investigated the clinical efficacy of direct hemoperfusion with a beta2-microglobulin (beta2-m) adsorption column for the treatment of patients with dialysis-related amyloidosis...
  13. ncbi Comparative efficacy of hemodialysis and hemoperfusion in severe theophylline intoxication
    M W Shannon
    Children s Hospital, Department of Pediatrics, Boston, MA 02115
    Acad Emerg Med 4:674-8. 1997
    To determine the comparative efficacy of hemoperfusion and hemodialysis for severe theophylline toxicity in concurrent case series.
  14. ncbi High-flux hemodialysis without hemoperfusion is effective in acute valproic acid overdose
    S L Kane
    College of Pharmacy, Ohio State University, Columbus 43210, USA
    Ann Pharmacother 34:1146-51. 2000
    To report a case of valproic acid overdose treated successfully with high-flux hemodialysis without the addition of charcoal hemoperfusion.
  15. ncbi Clinical outcome of hemoperfusion in poisoned patients
    Hyo Wook Gil
    Department of Internal Medicine, Soonchunhyang University Cheonan Hospital, Cheonan, Republic of Korea
    Blood Purif 30:84-8. 2010
    ..To define the safety and clinical outcomes of hemoperfusion, we evaluated retrospectively clinical outcomes of hemoperfusion over a 3-year period in our clinical center...
  16. ncbi Effect of direct hemoperfusion with a polymyxin B immobilized fiber column on high mobility group box-1 (HMGB-1) in severe septic shock: report of a case
    Yuichiro Sakamoto
    Department of Emergency and Critical Care Medicine, Chiba Hokisou Hospital, Nippon Medical School, Inba-gun, Chiba, Japan
    ASAIO J 52:e37-9. 2006
    ..Our patient, however, recovered from severe septic shock and was saved by the use of direct hemoperfusion with a polymyxin B immobilized fiber column (DHP-PMX)...
  17. ncbi Clinical evaluation of PMX-DHP for hypercytokinemia caused by septic multiple organ failure
    Toshiaki Ikeda
    Division of Critical Care and Emergency Medicine, Hachioji Medical Center, Tokyo Medical University, Tokyo, Japan
    Ther Apher Dial 8:293-8. 2004
    ..These results suggest that PMX-DHP could save more lives in patients with septic multiple organ failure with IL-6 = 1000 pg/mL when applied early after the onset of shock...
  18. ncbi Hemoperfusion with polymyxin B-immobilized fibers reduced the number of CD16+ CD14+ monocytes in patients with septic shock
    Hironori Tsujimoto
    Department of Surgery I, National Defense Medical College Research Institute, Saitama, Japan
    J Endotoxin Res 10:229-37. 2004
    BACKGROUND: CD16+ CD14+ monocytes dramatically increase in number in patients with severe infection. Hemoperfusion with PMX-F (direct hemoperfusion with polymyxin B immobilized fibers) has been reported to be a safe and effective ..
  19. ncbi Polymyxin B-immobilized fiber hemoperfusion after emergency surgery in patients with chronic renal failure
    Tamotsu Tojimbara
    Department of Surgery III, Kidney Center, Tokyo Women s Medical University, Tokyo, Japan
    Ther Apher Dial 8:286-92. 2004
    The purpose of this study was to evaluate the effect of direct hemoperfusion using a Polymyxin B (PMX) immobilized fiber column in septic patients with chronic renal failure after emergency surgery...
  20. ncbi Effect of polymyxin B-immobilized fiber on blood metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 levels in acute respiratory distress syndrome patients
    Tsukasa Nakamura
    Department of Medicine, Shinmatsudo Central General Hospital, Chiba, Japan
    Blood Purif 22:256-60. 2004
    ..01, TIMP-1 220.6 +/- 30.5 ng/ml, p < 0.01). CONCLUSION: These data suggest that MMP-9 and TIMP-1 may play a role in the pathogenesis of ARDS and that PMX-F treatment ameliorated increased MMP-9 and TIMP-1 levels in ARDS patients...
  21. ncbi Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial
    Dinna N Cruz
    Department of Nephrology, Dialysis, and Transplantation, St Bortolo Hospital and International Renal Research Institute Vicenza, 36100 Vicenza, Italy
    JAMA 301:2445-52. 2009
    ..Gram-negative-induced abdominal sepsis is likely associated with high circulating endotoxin. Reducing circulating endotoxin levels with polymyxin B hemoperfusion could potentially improve patient clinical outcomes.
  22. ncbi Effectiveness of polymyxin B-immobilized fiber column in sepsis: a systematic review
    Dinna N Cruz
    Department of Nephrology, Ospedale San Bortolo, Viale Rodolfi 37, 36100 Vicenza, Italy
    Crit Care 11:R47. 2007
    ..We performed a systematic review to describe the effect in septic patients of direct hemoperfusion with PMX-F on outcomes of blood pressure, use of vasoactive drugs, oxygenation, and mortality reported in ..
  23. ncbi Therapeutic efficacy of charcoal hemoperfusion in patients with acute severe dichlorvos poisoning
    Ai Peng
    Department of Medicine, Affiliated Drum Tower Hospital, School of Medicine, Nanjing University, Nanjing 210008, China
    Acta Pharmacol Sin 25:15-21. 2004
    To assess the efficacy of hemoperfusion (HP) in the treatment of the patients with acute severe dichlorvos (DDVP) poisoning.
  24. ncbi Hemoperfusion with an immobilized polymyxin B fiber column inhibits activation of vascular endothelial cells
    Hidehiko Kushi
    Department of Emergency and Critical Care Medicine, Nihon University School of Medicine, Tokyo, Japan
    Ther Apher Dial 9:303-7. 2005
    ..We therefore investigated whether direct hemoperfusion (DHP) with a polymyxin B immobilized fiber column (PMX) could reduce the level of plasminogen activator ..
  25. ncbi Effect of haemoperfusion on plasma paraquat concentration in vitro and in vivo
    Sae-Yong Hong
    Department of Internal Medicine and Clinical Research Institute, Soonchunhyang University College of Medicine, Cheonan, Korea
    Toxicol Ind Health 19:17-23. 2003
    ..3+/-19.9 versus 67.2+/-19.2%, P <0.01), we concluded that adequate HP appears to be an indispensable treatment for patients with acute PQ poisoning...
  26. ncbi Vascular endothelial growth factor and soluble fms-like tyrosine kinase-1 in septic shock patients treated with direct hemoperfusion with a polymyxin B-immobilized fiber column
    Itaru Ebihara
    Department of Nephrology, Mito Saiseikai General Hospital, Mito, Japan
    Ther Apher Dial 12:285-91. 2008
    ..Serum VEGF and soluble Flt-1 levels in 21 patients with septic shock, who were treated with direct hemoperfusion with a polymyxin B-immobilized fiber column (DHP-PMX), were measured by enzyme-linked immunoassay...
  27. ncbi A novel immunotherapeutic modality with direct hemoperfusion targeting transforming growth factor-beta prolongs the survival of tumor-bearing rats
    Yoshiki Yamamoto
    Department of Surgery, Division of Digestive Surgery, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan
    Oncol Rep 16:1277-84. 2006
    ..from tumor-bearing hosts, we developed an immunosuppressive substance adsorption (ISA) column for direct hemoperfusion (DHP) treatment. It is filled with extra-fine fibers that can adsorb TGF-beta...
  28. ncbi Polymyxin B-immobilized fiber hemoperfusion attenuates increased plasma atrial natriuretic peptide and brain natriuretic Peptide levels in patients with septic shock
    Tsukasa Nakamura
    Department of Medicine, Shinmatsudo Central General Hospital, Chiba, Japan
    ASAIO J 54:210-3. 2008
    Polymyxin B-immobilized fiber (PMX-F) hemoperfusion is reported to be safe and effective in septic shock patients...
  29. ncbi Endotoxin adsorption therapy for septic shock using polymyxin B-immobilized fibers (PMX): evaluation by high-sensitivity endotoxin assay and measurement of the cytokine production capacity
    Masahiro Kojika
    Department of Critical Care Medicine, Iwate Medical University, School of Medicine, Morioka, Japan
    Ther Apher Dial 10:12-8. 2006
    ..The 28-day mortality rate was 12%. PMX-direct hemoperfusion (PMX-DHP) was associated with elevation of the mean arterial pressure and urine output, reduction in the mean ..
  30. ncbi Anandamide absorption by direct hemoperfusion with polymixin B-immobilized fiber improves the prognosis and organ failure assessment score in patients with sepsis
    Shinji Kohro
    Department of Anesthesiology, Sapporo Medical University School of Medicine, South 1, West 16, Chuo-ku, Sapporo 060-8543, Japan
    J Anesth 20:11-6. 2006
    PURPOSE: Direct hemoperfusion (DHP) with polymixin B-immobilized fiber (PMX) has been reported to be effective for patients with septic shock. The aim of this study was to clarify the mechanism of PMX-DHP effect on septic shock...
  31. ncbi Hemoperfusion with an immobilized polymyxin B column reduces the blood level of neutrophil elastase
    Hidehiko Kushi
    Department of Emergency and Critical Care Medicine, Nihon University School of Medicine, Tokyo, Japan
    Blood Purif 24:212-7. 2006
    We investigated whether direct hemoperfusion with an immobilized polymyxin B column (DHP with PMX) could reduce the blood level of neutrophil elastase.
  32. ncbi The place of early haemoperfusion with polymyxin B fibre column in the treatment of sepsis
    Claudio Ronco
    Department of Nephrology, Dialysis and Transplantation, San Bortolo Hospital, Vicenza, Italy
    Crit Care 9:631-3. 2005
    ..This commentary considers whether the available evidence allows us to establish an appropriate role for PMX-F treatment in sepsis and what further work is needed...
  33. ncbi Relationship between treatment resistance to hemoperfusion using a polymyxin B-immobilized fiber column and oxidative stress
    Yuichiro Sakamoto
    Department of Emergency and Critical Care Medicine, Chiba Hokusoh Hospital, Nippon Medical School, Japan
    ASAIO J 54:412-5. 2008
    ..Recent reports have suggested that direct hemoperfusion with a polymyxin B-immobilized fiber column (DHP-PMX) may improve the oxygenation in patients with acute lung ..
  34. ncbi In acute organophosphate poisoning, the efficacy of hemoperfusion on clinical status and mortality
    Levent Altintop
    Department of Internal Medicine, Ondokuz Mayis University, School of Medicine, Samsun, Turkey
    J Intensive Care Med 20:346-50. 2005
    ..to report experience in patients with organophosphate poisoning (OPP) and to discuss the potential role for hemoperfusion (HP) in the management of severe OPP...
  35. ncbi Early hemoperfusion with an immobilized polymyxin B fiber column eliminates humoral mediators and improves pulmonary oxygenation
    Hidehiko Kushi
    Department of Emergency and Critical Care Medicine, Nihon University School of Medicine, 30 1 Oyaguchi Kamimachi, Tokyo, 173 8610, Japan
    Crit Care 9:R653-61. 2005
    The objective of this study was to clarify the efficacy and mechanism of action of direct hemoperfusion with an immobilized polymyxin B fiber column (DHP-PMX) in patients with acute lung injury or acute respiratory distress syndrome ..
  36. ncbi A pilot-controlled study of a polymyxin B-immobilized hemoperfusion cartridge in patients with severe sepsis secondary to intra-abdominal infection
    Jean Louis Vincent
    Department of Intensive Care, Erasme Hospital, Free University of Brussels, Brussels, Belgium
    Shock 23:400-5. 2005
    Endotoxin is an important pathogenic trigger for sepsis. The polymyxin B-immobilized endotoxin removal hemoperfusion cartridge, Toraymyxin (hereafter PMX), has been shown to remove endotoxin in preclinical and open-label clinical studies...
  37. ncbi Effect over time of endotoxin adsorption therapy in sepsis
    Takuya Ueno
    Department of Surgery, Kitasato University School of Medicine, Kanagawa, Japan
    Ther Apher Dial 9:128-36. 2005
    ..In recent years, endotoxin adsorption therapy (PMX-DHP, polymyxin-direct hemoperfusion) has been widely used in Japan to remove endotoxin, a causative agent of sepsis...
  38. ncbi Endotoxin adsorption by polymyxin B immobilized fiber column in patients with systemic inflammatory response syndrome: the Japanese experience
    Takashi Sato
    Kidney Center, Koga Hospital, Kurume, Fukuoka Japan
    Ther Apher Dial 7:252-8. 2003
    ..Further studies are needed to clarify the mechanisms of PMX treatment and to strengthen the scientific basis of this treatment...
  39. ncbi Hemoperfusion with polymyxin B-immobilized fiber in septic patients with methicillin-resistant Staphylococcus aureus-associated glomerulonephritis
    Tsukasa Nakamura
    Department of Medicine, Misato Junshin Hospital, Saitama, Japan
    Nephron Clin Pract 94:c33-9. 2003
    ..CONCLUSION: PMX-F treatment may be effective in reducing urinary protein and urinary podocyte excretion in septic patients with MRSA-associated glomerulonephritis...
  40. ncbi Direct hemoperfusion using a polymyxin B immobilized column improves acute respiratory distress syndrome
    Kenji Tsushima
    First Department of Internal Medicine, Shinshu University School of Medicine, Asahi, Matsumoto, Japan
    J Clin Apher 17:97-102. 2002
    ..We have studied whether direct hemoperfusion using a polymyxin B immobilized fiber column (PMX-DHP) is effective for acute lung injury (ALI) and ARDS...
  41. ncbi The severity of hyperdynamic circulation may predict the effects of direct hemoperfusion with the adsorbent column using polymyxin B-immobilized fiber in patients with gram-negative septic shock
    K Uriu
    Kidney Center, and Division of Critical Care Medicine, University of Occupational and Environmental Health School of Medicine, Kitakyusyu, Japan
    Ther Apher 5:25-30. 2001
    It has been reported that direct hemoperfusion with the adsorbent column using polymyxin B-immobilized fiber (DHP with PMX-F column) ameliorates hyperdynamic circulation in septic shock and improves survival rate...
  42. ncbi Hemoperfusion with polymyxin B immobilized fibers for urinary albumin excretion in septic patients with trauma
    Tsukasa Nakamura
    Department of Medicine, Misato Junshin Hospital, Saitama, Japan
    ASAIO J 48:244-8. 2002
    ..Plasma endotoxin levels were determined by endospecy test. Hemoperfusion with PMX-F was carried out twice, for 2 hours, at a flow rate of 100 ml/min...
  43. ncbi Combination therapy with polymyxin B-immobilized fibre haemoperfusion and teicoplanin for sepsis due to methicillin-resistant Staphylococcus aureus
    T Nakamura
    Department of Medicine, Misato Junshin Hospital, Saitama, Japan
    J Hosp Infect 53:58-63. 2003
    ..001). The mean duration of stay was 44, 42, 28 and 56 days in groups A, B, C and D, respectively. Our data suggest that combination therapy with PMX-F and teicoplanin is effective for sepsis caused by MRSA...
  44. ncbi Endotoxin removal by direct hemoperfusion with an adsorbent column using polymyxin B-immobilized fiber ameliorates systemic circulatory disturbance in patients with septic shock
    Kohei Uriu
    Kidney Center, First Department of Internal Medicine, University of Occupational and Environmental Health School of Medicine, Kitakyusyu, Japan
    Am J Kidney Dis 39:937-47. 2002
    Direct hemoperfusion (DHP) with an adsorbent column using polymyxin B-immobilized fiber (PMX-F) has been shown to improve the state of shock in patients with septic shock...
  45. ncbi Newly developed immobilized polymyxin B fibers improve the survival of patients with sepsis
    H Nemoto
    Department of Nephrology and Kidney Disease Center, Saitama Medical College, Saitama, Japan
    Blood Purif 19:361-8; discussion 368-9. 2001
    ..However, in severe sepsis, this therapy does not improve the survival rate...
  46. ncbi Failure of continuous venovenous hemofiltration to prevent death in paraquat poisoning
    Ja Ryong Koo
    Division of Nephrology, College of Medicine, Hallym University, Chunchon, Kangwon Do, Seoul, Korea
    Am J Kidney Dis 39:55-9. 2002
    ..The amount ingested was 2.1 +/- 1.0 mouthfuls (as 20% concentrate). All patients were treated with hemoperfusion (HP; duration, 6.4 +/- 3...
  47. ncbi Modulation of human leukocyte antigen-DR on monocytes and CD16 on granulocytes in patients with septic shock using hemoperfusion with polymyxin B-immobilized fiber
    Satoshi Ono
    Department of Surgery I, National Defense Medical College, Namiki 3 2, Tokorozawa, Saitama 359 8513, Japan
    Am J Surg 188:150-6. 2004
    b>Hemoperfusion with PMX-F (polymyxin B covalently immobilized on fibers) has been reported to be safe and effective for patients with septic shock. However, the molecular mechanism of this usefulness is not yet clear...
  48. ncbi Dose-related effects of direct hemoperfusion using a cytokine adsorbent column for the treatment of experimental endotoxemia
    Takumi Taniguchi
    Department of Emergency and Critical Care Medicine, Graduate School of Medical Science, Kanazawa University, 13 1 Takara machi, 920 8641, Kanazawa, Japan
    Intensive Care Med 33:529-33. 2007
    To clarify the dose-related effects of direct hemoperfusion using a cytokine adsorbent column (CTR) on the mortality and inflammatory responses to endotoxin-induced shock in rats.
  49. ncbi Effects of polymyxin B-immobilized fiber hemoperfusion on amino acid imbalance in septic encephalopathy
    Tsukasa Nakamura
    Department of Medicine, Shinmatsudo Central General Hospital, Chiba, Japan
    Blood Purif 21:282-6. 2003
    ..acids is altered in patients with septic encephalopathy and whether polymyxin B-immobilized fiber (PMX-F) hemoperfusion affects this balance...
  50. ncbi Hemoadsorption in critical care
    Toshiaki Ikeda
    Division of Critical Care and Emergency Medicine, Hachiouji Medical Center, Tokyo Medical University, Tokyo, Japan
    Ther Apher 6:189-92. 2002
    ..These results suggest favorable effects of endotoxin hemoadsorption on the hemodynamic and pathophysiological conditions in patients with septic shock although attention should be given to the decrease in platelet count...
  51. ncbi Use of hemodialysis and hemoperfusion in poisoned patients
    William J Holubek
    Department of Emergency Medicine, New York Methodist Hospital, New York, New York, USA
    Kidney Int 74:1327-34. 2008
    Extracorporeal removal techniques such as hemodialysis, charcoal hemoperfusion, and peritoneal dialysis have been used to remove toxins from the body...
  52. ncbi Polymyxin-B hemoperfusion inactivates circulating proapoptotic factors
    Vincenzo Cantaluppi
    Dipartimento di Medicina Interna, Centro Ricerca Medicina Sperimentale CeRMS, Torino, Italy
    Intensive Care Med 34:1638-45. 2008
    ..To test the hypothesis that extracorporeal therapy with polymyxin B (PMX-B) may prevent Gram-negative sepsis-induced acute renal failure (ARF) by reducing the activity of proapoptotic circulating factors...
  53. ncbi Effects of hemoperfusion on serum cardiac troponin T concentrations using polymyxin B-immobilized fibers in septic patients undergoing hemodialysis
    Tsukasa Nakamura
    Department of Medicine, Misato Junshin Hospital, Saitama, Japan
    ASAIO J 48:41-4. 2002
    ..PMX-F is effective in reducing myocardial damage, in part, due to reducing plasma endotoxin levels...
  54. ncbi How tightly can a drug be bound to a protein and still be removable by charcoal hemoperfusion in overdose cases?
    Chiyo I Kawasaki
    Department of Pharmacy, Japanese Red Cross Kumamoto Hospital, Kumamoto, Japan
    Clin Toxicol (Phila) 43:95-9. 2005
    Charcoal hemoperfusion is a very effective extracorporeal treatment in cases of drug overdose. The volume of distribution of a drug is the most important factor in limiting the efficacy of the treatment...
  55. ncbi Polymyxin B-immobilized fiber hemoperfusion with low priming volume in an elderly septic shock patient with marked endotoxemia
    Tsukasa Nakamura
    Department of Medicine, Shinmatsudo Central General Hospital, Chiba, Japan
    ASAIO J 51:482-4. 2005
    ..However, her plasma endotoxin level remained high for 3 days. We performed direct hemoperfusion twice using a polymyxin B-immobilized fiber (PMX-F) column with a low priming volume...
  56. ncbi Physiological response to superantigen-adsorbing hemoperfusion in toxin-concentration-controlled septic swine
    Keishi Miwa
    New Frontiers Research Laboratories, Toray Industries, Inc, Kanagawa, Japan
    Blood Purif 24:319-26. 2006
    ..The effects of hemoadsorption with a superantigen-adsorbing device (SAAD) were evaluated in septic swine...
  57. ncbi [Experimental study on a novel affinity adsorbent for removal of endotoxin in plasma]
    Yuan Li
    Key Lab for Biomechanical and Tissue Engineering under the State Ministry of Education, Chongqing University, Chongqing 400044, China
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 23:832-5. 2006
    ..The rat models of endotoxemia were established, which were used in hemoperfusion. The experiment results indicated that the novel affinity adsorbent could remove endotoxin from plasma ..
  58. ncbi [Experience of direct hemoperfusion using polymyxin B-immobilized fiber on patients with endotoxin shock from urosepsis]
    H Ushida
    Department of Urology, Uji Tokushukai Hospital
    Hinyokika Kiyo 47:329-31. 2001
    We report the effects of direct hemoperfusion using polymyxin B-immobilized fiber (PMX treatment) on two patients with endotoxin shock from urosepsis...
  59. ncbi Changes of cytokines in direct endotoxin adsorption treatment on postoperative multiple organ failure
    N Matsuno
    Fifth Department of Surgery, Hachioji Medical Center, Tokyo Medical University, Hachioji-city, Japan
    Ther Apher 5:36-9. 2001
    ..therapy with the endotoxin adsorption column containing polymyxin B immobilized fibers by direct hemoperfusion (PMX-DHP) is reportedly effective in the treatment of septic shock...
  60. ncbi Hemoperfusion with an immobilized polymyxin B fiber column reduces circulating interleukin-8 concentrations
    Hidehiko Kushi
    Department of Emergency and Critical Care Medicine, Nihon University School of Medicine, Tokyo, Japan
    Ther Apher Dial 10:425-9. 2006
    In the present study, we examined whether the performance of hemoperfusion with an immobilized polymyxin B fiber column (DHP-PMX) reduces circulating interleukin-8 concentration in patients with sepsis...
  61. ncbi Clinical responses and improvement of some laboratory parameters following polymyxin B-immobilized fiber treatment in septic shock
    Yuichiro Sakamoto
    Department of Emergency and Critical Care Medicine, Chiba Hokusoh Hospital, Nippon Medical School, Inba gun, Chiba, Japan
    ASAIO J 53:646-50. 2007
    Direct hemoperfusion using a polymyxin B-immobilized fiber column (PMX; Toray Industries Inc., Tokyo, Japan) was first developed in 1994 and has since been used for the treatment of septic shock...
  62. ncbi Clinical effects of use polymyxin B fixed on fibers in liver transplant patients with severe sepsis or septic shock
    F Ruberto
    Dipartimento di Scienze Anestesiologiche, Medicina Critica e Terapia del Dolore, Universita degli Studi di Roma La Sapienza, Roma, Italy
    Transplant Proc 39:1953-5. 2007
    ..An extracorporeal hemoperfusion device (TORAYMYXIN) has been developed: PMX is covalently bound to the surface of an insoluble carrier ..
  63. ncbi Endotoxin removal with a polymyxin B-immobilized hemoperfusion cartridge improves cardiopulmonary function after cardiopulmonary bypass
    Shigeru Ohki
    Department of Thoracic and Visceral Organ Surgery, Gunma University Graduate School of Medicine, Gunma, Japan
    J Surg Res 145:74-9. 2008
    ..We evaluated the effectiveness of endotoxin removal with a polymyxin B-immobilized hemoperfusion cartridge (PMX) in CPB.
  64. ncbi Polymyxin B-immobilized fiber hemoperfusion with the PMX-05R column in elderly patients suffering from septic shock
    Tsukasa Nakamura
    Department of Medicine, Shinmatsudo Central General Hospital, Chiba, Japan
    Am J Med Sci 334:244-7. 2007
    Direct hemoperfusion with the polymyxin B-immobilized fiber (PMX-20R) column has a positive effect on outcome in patients with sepsis or septic shock...
  65. ncbi A targeted extracorporeal therapy for endotoxemia: the time has come
    John A Kellum
    The CRISMA Laboratory, Critical Care Medicine, University of Pittsburgh, Terrace Street, Pittsburgh, PA 15261, USA
    Crit Care 11:137. 2007
    ..High levels of endotoxin activity are associated with worse clinical outcomes. In Japan, polymyxin B hemoperfusion has been available to treat endotoxemia for more than ten years...
  66. ncbi Relationship between effect of polymyxin B-immobilized fiber and high-mobility group box-1 protein in septic shock patients
    Yuichiro Sakamoto
    Department of Emergency and Critical Care Medicine, Chiba Hokusoh Hospital, Nippon Medical School, Chiba, Japan
    ASAIO J 53:324-8. 2007
    Direct hemoperfusion (DHP) using a polymyxin B (PMX)-immobilized fiber column has been used for treatment of endotoxemia-induced septic shock in Japan since 1994 and is now an accepted therapy for reducing serum endotoxin levels...
  67. ncbi Intraoperative endotoxin adsorption as a new therapeutic option for mycotic aortic aneurysm
    Toshinori Totsugawa
    Department of Cardiovascular Surgery, The Sakakibara Heart Institute of Okayama, Okayama, Japan
    Circ J 72:161-3. 2008
    ..Direct hemoperfusion using polymyxin B-immobilized fiber (PMX-DHP) was intraoperatively carried out in parallel with the ..
  68. ncbi Effects of PMX-DHP treatment for patients with directly induced acute respiratory distress syndrome
    Kenji Tsushima
    First Department of Internal Medicine, Shinshu University School of Medicine, Asahi, Matsumoto, Japan
    Ther Apher Dial 11:138-45. 2007
    Endotoxin-removal direct hemoperfusion column containing polymyxin B immobilized fibers (PMX-DHP) is an effective procedure for the treatment of sepsis-induced acute respiratory distress syndrome (ARDS)...
  69. ncbi Effects of combination therapy with direct hemoperfusion using polymyxin B-immobilized fiber and oral vancomycin on fulminant pseudomembranous colitis with septic shock
    Yoshihide Kimura
    Department of Internal Medicine, Nagoya City Johoku Hospital, 2 15 Kaneda cho, Kita ku, Nagoya 462 0033, Japan
    Dig Dis Sci 52:675-8. 2007
    ..Direct hemoperfusion using polymyxin B-immobilized fiber, which was previously demonstrated to have excellent therapeutic effects ..
  70. ncbi Endotoxin apheresis for sepsis
    Tomoharu Shimizu
    Department of Surgery, Shiga University of Medical Science, Shiga, Japan
    Transfus Apher Sci 35:271-82. 2006
    ..Lixelle and CTR which have recently been shown to remove circulating bacterial components are also included in this review...
  71. ncbi Extracorporeal endotoxin adsorption in septic patients--does it work?
    Guido Grass
    Crit Care Med 32:1792-3. 2004
  72. ncbi Blood purification therapy for sepsis
    Hiromi Sakata
    Department of Surgery, Sapporo Hokuyu Hospital, Research Institute for Artificial Organs, Transplantation and Gene Therapy, 6-6-5-1, Higashi Sapporo, Shiroishi-ku, Sapporo, Hokkaido 003-0006, Japan
    Transfus Apher Sci 35:245-51. 2006
    ..Blood purification therapy including polymyxin B-immobilized hemoperfusion cartridge and continuous hemodiafiltration has shown the beneficial effect on patients with sepsis in Japan...
  73. ncbi Clinical effects of direct hemoperfusion using a polymyxin-B immobilized column in solid organ transplanted patients with signs of severe sepsis and septic shock. A pilot study
    F Ruberto
    Department of Anesthesiology, Critical Care Medicine and Pain Therapy, Sapienza University of Rome, Rome, Italy
    Int J Artif Organs 30:915-22. 2007
    ..An extracorporeal hemoperfusion device (TORAYMYXIN) has been developed: PMX is covalently bound on the surface of an insoluble carrier ..
  74. ncbi Polymyxin B-immobilized fiber hemoperfusion in a patient with active ulcerative colitis
    Tsukasa Nakamura
    Department of Medicine, Shinmatsudo Central General Hospital, Chiba, Japan
    ASAIO J 51:471-3. 2005
    ..0 pg/ml; normal < 9.8 pg/ml). She underwent polymyxin B-immobilized fiber (PMX-F) hemoperfusion therapy twice...
  75. ncbi Early hemoperfusion with a polymyxin b column improves gastric intramucosal pH in sepsis
    Hidehiko Kushi
    Department of Emergency and Critical Care Medicine, Nihon University School of Medicine, Tokyo, Japan
    Ther Apher Dial 12:278-84. 2008
    ..The other was to determine whether direct hemoperfusion with a polymyxin B fiber column (DHP-PMX) could improve the pHi if it remained low after early goal-directed ..
  76. ncbi Selection of hemoperfusion therapy for patients with septic shock on the basis of the primary disease
    Yoshihiko Kanno
    Department of Nephrology, Saitama Medical School, Moroyama-machi, Iruma-gun, Saitama 350-0495, Japan
    J Artif Organs 6:205-10. 2003
    ..There were no significant differences between the two groups in age or the Apache II scores at the start of hemoperfusion treatment; however, the gender ratio varied: 72% of the cardiovascular group were male, compared to 46% of the ..
  77. ncbi Open randomized phase II trial of an extracorporeal endotoxin adsorber in suspected Gram-negative sepsis
    Konrad Reinhart
    Department of Anesthesiology and Intensive Care Medicine, Friedrich-Schiller University of Jena, Bachstrasse 18, 07743 Jena, Germany
    Crit Care Med 32:1662-8. 2004
    ..There were no clinically important side effects. These results provide encouragement for further study of adsorber treatment in patients with high likelihood of Gram-negative sepsis (e.g., peritonitis)...
  78. ncbi [Hemoperfusion]
    Shigeo Negi
    Center of Blood Purification Therapy, Wakayama Medical University
    Nippon Rinsho 62:343-6. 2004
  79. ncbi [Clinical experiences of endotoxin removal in urinary obstruction: report of two cases]
    Motohiko Sugi
    Department of Urology, Iseikai Hospital
    Hinyokika Kiyo 50:685-9. 2004
    ..Under the diagnosis of septic shock, left nephrostomy were performed. Direct hemoperfusion using polymyxin B immobilized fiber column was carried out...
  80. ncbi Criteria for direct hemoperfusion with an immobilized polymyxin B fiber column based on oxygen metabolism
    Hidehiko Kushi
    Department of Emergency and Critical Care Medicine, Nihon University School of Medicine, Tokyo, Japan
    Ther Apher Dial 12:292-7. 2008
    The optimum time for commencement of direct hemoperfusion with a polymyxin B immobilized fiber column (DHP-PMX) in patients with sepsis remains unclear...
  81. ncbi [Polymyxin-B direct hemoperfusion (PMX-DHP) in gram negative sepsis]
    A F Perego
    A O Ospedale Niguarda Ca, Granda, Milano
    G Ital Nefrol 23:S94-102. 2006
    ..The polymyxin B cartridge is an extracorporeal hemoperfusion device (PMX-DHP) known to remove circulating endotoxins...
  82. ncbi [Acute blood purification for septic multiple organ failure]
    Makoto Kobayashi
    Hyogo Emergency Medical Center
    Nippon Rinsho 62:2308-12. 2004
    ..Direct hemoperfusion with polymyxin B immobilized fiber (PMX-DHP) can rapidly improve circulation and decrease blood levels of ..
  83. ncbi Clinical effects of polymyxin B-immobilized fiber column in septic patients
    Dinna N Cruz
    Department of Nephrology, Ospedale San Bortolo, Vicenza, Italy
    Contrib Nephrol 156:444-51. 2007
    ..Direct hemoperfusion with polymyxin-B-immobilized fiber (PMX-F) is a promising treatment of gram-negative sepsis in critically ill ..
  84. ncbi A new therapeutic strategy for streptococcal toxic shock syndrome: a key target for cytokines
    Takayuki Kawaguchi
    Department of Internal Medicine, Takasago Municipal Hospital, Takasago
    Intern Med 42:211-8. 2003
    ..Direct hemoperfusion with polymyxin B-immobilized fiber improved the hemodynamics in all three patients who had developed shock at ..
  85. ncbi Emerging technologies in extracorporeal treatment: focus on adsorption
    Sergey V Mikhalovsky
    School of Pharmacy and Biomolecular Sciences, University of Brighton, Brighton, UK
    Perfusion 18:47-54. 2003
    ..Since the 1990s interest in the use of adsorbents in extracorporeal medical devices has been rising again. In this paper some recent developments in synthesis and application of novel uncoated medical adsorbents are discussed...
  86. ncbi Effect of hemoperfusion using polymyxin B-immobilized fiber on IL-6, HMGB-1, and IFN gamma in a neonatal sepsis model
    Mohamed Hamed Hussein
    Department of Pediatrics, Neonatology and Congenital Disorders, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
    Pediatr Res 58:309-14. 2005
    To evaluate effects of polymyxin B direct hemoperfusion (PMX-DHP) on a neonatal sepsis cecal ligation and perforation (CLP) model, in 24 anesthetized and mechanically ventilated 3-d-old piglets, 16 were assigned to CLP and an ..
  87. ncbi The effect of continuous veno-venous hemofiltration or direct hemoperfusion with polymyxin B-immobilized fiber on neutrophil respiratory oxidative burst in patients with sepsis and septic shock
    Toshio Naka
    Department of Critical Care Medicine, Wakayama Medical University, Wakayama, Japan
    Ther Apher Dial 10:7-11. 2006
    ..Blood purification therapies such as continuous veno-venous hemofiltration (CVVH) and direct hemoperfusion with polymyxin-immobilized fiber (PMX-DHP) have been used for the treatment of sepsis and septic shock, ..
  88. ncbi Changes in circulating levels of calcitonin gene-related peptide and nitric oxide metabolites in septic patients during direct hemoperfusion with polymyxin B-immobilized fiber
    Tomoharu Shimizu
    PMX Hemodynamics Study Group, Shiga University of Medical Science, Shiga, Japan
    Blood Purif 21:237-43. 2003
    ..We conclude that a decrease in CGRP levels may be related to hemodynamic improvement resulting from PMX treatments...
  89. ncbi Aconite poisoning
    Thomas Y K Chan
    Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong, China
    Clin Toxicol (Phila) 47:279-85. 2009
    ..However, the use of a larger than recommended dose and inadequate processing increases the risk of poisoning...
  90. ncbi Hemodialysis: a therapeutic option for severe attacks of acute intermittent porphyria in developing countries
    Murugesan R Prabahar
    Department of Nephrology, Sri Ramachandra University, Chennai, India
    Hemodial Int 12:34-8. 2008
    ..Hemodialysis and hemoperfusion have been tried in the treatment of acute attacks of AIP with success...
  91. ncbi Extracorporeal blood detoxification by sorbents in treatment of hepatic encephalopathy
    Stephen R Ash
    Dialysis Center for Greater Lafayette, West Lafayette, IN 47906, USA
    Adv Ren Replace Ther 9:3-18. 2002
    ..by sorbent therapy long has been applied in treatment of hepatic failure and encephalopathy, starting with hemoperfusion columns and more recently with the currently marketed Liver Dialysis Unit...
  92. ncbi Intravenous lipid emulsions combine extracorporeal blood purification: a novel therapeutic strategy for severe organophosphate poisoning
    Yaguang Zhou
    Department of Intensive Care Unit, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
    Med Hypotheses 74:309-11. 2010
    ..Extracorporeal blood purification especially charcoal hemoperfusion is an efficient way to eliminate the poison contents from the blood...
  93. ncbi [Liver support systems today]
    Csaba Rikker
    Péterfy Sándor Utcai Kórház Rendelointézet és Baleseti Központ, Fresenius Medical Care Dialízisközpont, Budapest
    Orv Hetil 150:2299-307. 2009
    ..Early devices including hemodialysis, hemoperfusion, exchange transfusion, cross-hemodialysis, cross-circulation and plasmapheresis appeared inefficient...
  94. ncbi Functional sorbents for selective capture of plutonium, americium, uranium, and thorium in blood
    Wassana Yantasee
    Biomedical Engineering, Oregon Health and Science University, Portland, OR 97239, USA
    Health Phys 99:413-9. 2010
    ..for critical exposure cases, reduction of nonspecific dose during actinide radiotherapy, and for sorbent hemoperfusion in renal insufficient patients, whose kidneys clear radionuclides at a very slow rate...
  95. ncbi Limited efficacy of gastrointestinal decontamination in severe slow-release carbamazepine overdose
    Yael Lurie
    Israel Poison Information Center, Rambam Health Care Campus, The Bruce Rappaport Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel
    Ann Pharmacother 41:1539-43. 2007
    ..To report the limited efficacy of both multiple doses of activated charcoal (MDAC) and whole bowel irrigation (WBI) in a patient with severe overdose of slow-release carbamazepine...
  96. ncbi Effectiveness of hemodialysis in the extracorporeal therapy of phenobarbital overdose
    B F Palmer
    Division of Nephrology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA
    Am J Kidney Dis 36:640-3. 2000
    ..In severely compromised patients, both hemodialysis and hemoperfusion have been used to enhance elimination of the drug...
  97. ncbi Polymers in nephrology. Characteristics and needs
    J Vienken
    Bioscience Department, Fresenius Medical Care, Bad Homburg, Germany
    Int J Artif Organs 25:470-9. 2002
    ..tubing-systems for extracorporeal circuits and - in the form of beads - act as parts of adsorber columns for hemoperfusion or immunoadsorption...
  98. ncbi Mechanisms of polymyxin B endotoxin removal from extracorporeal blood flow: molecular interactions
    S Vesentini
    Department of Bioengineering, Politecnico di Milano, IT 20132 Milan, Italy
    Contrib Nephrol 167:45-54. 2010
    ..Extracorporeal hemoperfusion treatments based on cartridges containing PMB-immobilized fibers (Toraymyxin PMX-F; Toray Industries, Tokyo, ..
  99. ncbi Suicide victim of paraquat poisoning make suitable corneal donor
    Tsung Yu Tsai
    Department of Nephrology and Division of Clinical Toxicology, Chang Gung Memorial Hospital, 199 Tung Hwa North Road, Taipei 105, Taiwan
    Hum Exp Toxicol 30:71-3. 2011
    ..Blood paraquat level was 1.90 μg/mL. Charcoal hemoperfusion was performed for 8 hours using a charcoal-containing dialysis machine...
  100. ncbi [Application of continuous renal replacement therapy in the rescue of MODS patients]
    Xiao miao Cheng
    Department of Nephrology, Xiangya Hospital, Central South University, Changsha 410008, China
    Zhong Nan Da Xue Xue Bao Yi Xue Ban 31:580-3. 2006
    ..To investigate the effect of continuous renal replacement therapy (CRRT) on patients with emergency and serious diseases...
  101. ncbi Effectiveness of endotoxin scattering photometry for determining the efficacy of polymyxin B-immobilized fiber treatment in septic shock: report of a case
    Yuichiro Sakamoto
    Department of Emergency and Critical Care Medicine, Graduate School of Medicine, Nippon Medical School
    J Nippon Med Sch 77:119-22. 2010
    ..On the other hand, the technique of direct hemoperfusion with a polymyxin B immobilized fiber column (DHP-PMX) was developed in Japan in 1994 and has been used for the ..

Research Grants40

  1. Systems Engineering of Pheresis Intervention for Sepsis
    John Kellum; Fiscal Year: 2007
    ..We will also call on the expertise of two companies, one specializing in adsorbent polymer technology (MedaSorb Technologies, LLC) and the other in complex systems modeling (Immunetrics, Inc.). ..
  2. Systems Engineering of Pheresis Intervention for Sepsis
    John Kellum; Fiscal Year: 2009
    ..We will also call on the expertise of two companies, one specializing in adsorbent polymer technology (MedaSorb Technologies, LLC) and the other in complex systems modeling (Immunetrics, Inc.). ..
  3. MethLock vs. heparin as dialysis catheter lock
    Stephen Ash; Fiscal Year: 2007
    ..In Phase II we will implement the protocol in a number of dialysis centers and complete the study as originally proposed or as modified after Phase I. ..
  4. Pheresis Treatment of Bioterrorism-Induced Sepsis
    Stephen Ash; Fiscal Year: 2005
    ..The safety systems of the existing PF system will be modified to meet the needs of the stand-alone system. Finally, an animal model of sepsis will be used to check efficacy and safety of the entire system. ..
  5. Nephrogenic Systemic Fibrosis (NSF): A Rodent Model for Therapeutic Intervention
    Wassana Yantasee; Fiscal Year: 2010
    ....
  6. IMMUNOGENICITY OF A XENOGENEIC BIOARTIFICAL LIVER
    Scott Nyberg; Fiscal Year: 2003
    ..A better understanding of the immune response in recipients will improve BAL therapy. ..
  7. XENOGENEIC BIOARTIFICAL LIVER
    Scott L Nyberg; Fiscal Year: 2010
    ..Demonstration of efficacy in a pre-clinical model of FHF, as proposed in this application, will provide a basis for future clinical trials of the spheroid reservoir BAL. ..
  8. Protocolized Goal-directed Resuscitation of Septic Shock to Prevent AKI (ProGReSS
    John A Kellum; Fiscal Year: 2010
    ....
  9. Biological Markers of Recovery for the Kidney
    John A Kellum; Fiscal Year: 2010
    ..For analyses requiring serial samples and urine samples, we propose to study a subset of trial patients enrolled at 5 sites who consent to additional sample collection (208 patients) ..
  10. Biological Markers of Recovery for the Kidney
    John Kellum; Fiscal Year: 2007
    ..For analyses requiring serial samples and urine samples, we propose to study a subset of trial patients enrolled at 5 sites who consent to additional sample collection (208 patients) ..
  11. A Hemoadsorptive Device for the Treatment of SIRS
    James Winchester; Fiscal Year: 2004
    The overall objective of the proposed project is to develop a hemoperfusion device for the clinical treatment of sepsis and other conditions related to the Systemic Inflammatory Response Syndrome (SIRS). RenalTech International and Dr...
  12. Pediatric Transplant Infections and Outcomes
    Vikas Dharnidharka; Fiscal Year: 2006
    ..abstract_text> ..